federal_register: 2014-07898

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2014-07898 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period Notice The Food and Drug Administration (FDA) is extending to May 7, 2014, the comment period for the notice that appeared in the Federal Register of January 7, 2014 (79 FR 830). In the notice, FDA requested comments on a draft guidance document entitled "Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. 2014-04-09 2014 4 https://www.federalregister.gov/documents/2014/04/09/2014-07898/blood-glucose-monitoring-test-systems-for-prescription-point-of-care-use-draft-guidance-for-industry https://www.govinfo.gov/content/pkg/FR-2014-04-09/pdf/2014-07898.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is extending to May 7, 2014, the comment period for the notice that appeared in the Federal Register of January 7, 2014 (79 FR 830). In the notice, FDA requested comments on a draft guidance document entitled...  

Links from other tables